IP Library Granted Patent US 10,471,036
Granted Patent B2
US 10,471,036 · App. 13/942,122 · Granted Nov 12, 2019

Antimicrobial compositions and methods

Inventors: Matthew T. Scholz (Woodbury, MN); Dianne L. Gibbs (St. Paul, MN); John T. Capecchi (Oakdale, MN); Jeffrey F. Andrews (Stillwater, MN)
Assignee: 3M Innovative Properties Company
A61K31/23A61K9/007A61K9/0014A61K9/0043A61K9/0046A61K9/0053A61K31/19A61K31/231A61K31/25A61K45/06A61K47/06A61K47/10A61K47/12A61K47/14A61K47/20A61K47/44Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,471,036
App. No.
13/942,122
Granted
Nov 12, 2019
Kind
B2
Abstract

Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including, in particular, an antimicrobial lipid component, such as a fatty acid ester, fatty ether, or alkoxide derivative thereof. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and/or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and/or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).

Claims (28)

1. An antimicrobial composition comprising:

an effective amount of an antimicrobial lipid component comprising a (C8-C12)saturated fatty acid ester of a polyhydric alcohol, a (C12-C22)unsaturated fatty acid ester of a polyhydric alcohol, a (C8-C12)saturated fatty ether of a polyhydric alcohol, a (C12-C22)unsaturated fatty ether of a polyhydric alcohol, an alkoxylated derivative thereof, or combinations thereof, wherein the alkoxylated derivative has less than 5 moles of alkoxide per mole of polyhydric alcohol; with the proviso that for polyhydric alcohols other than sucrose, the esters comprise monoesters and the ethers comprise monoethers, and for sucrose the esters comprise monoesters, diesters, or combinations thereof, and the ethers comprise monoethers, diethers, or combinations thereof; wherein for monoesters, monoethers, or alkoxylated derivatives thereof, there is no more than 15 wt-% of a diester, diether, triester, triether, or alkoxylated derivatives thereof present, based on the total weight of the antimicrobial lipid components present in the composition;

an effective amount of an enhancer component comprising an alpha-hydroxy acid, a beta-hydroxy acid, a chelating agent, a (C1-C4)alkyl carboxylic acid, a (C6-C12)aryl carboxylic acid, a (C6-C12)aralkyl carboxylic acid, a (C6-C12)alkaryl carboxylic acid, a phenolic compound, a (C1-C10)alkyl alcohol, an ether glycol, or combinations thereof;

a surfactant; and

a hydrophilic component other than water, wherein the hydrophilic component other than water forms the greatest portion of the composition by weight;

and wherein the composition contains less than 10 wt-% water when ready to use.

2. The antimicrobial composition of claim 1 , wherein the antimicrobial lipid is present in an amount of at least 0.5 wt-% and no greater than 20 wt-%.

3. The antimicrobial composition of claim 1 , wherein the C8-C12 saturated fatty acid ester of a polyhydric alcohol in the antimicrobial lipid is a C8-C12 alkyl monoesters of glycerin and propylene glycol, and the C8-C12 saturated fatty acid ether of a polyhydric alcohol is C8-C12 alkyl monoethers of glycerin and propylene glycol.

4. The antimicrobial composition of claim 1 , wherein the antimicrobial lipid component comprises glycerol monolaurate, glycerol monocaprate, glycerol monocaprylate, propylene glycol monolaurate, propylene glycol monocaprate, propylene glycol monocaprylate, or combinations thereof.

5. The antimicrobial composition of claim 1 , wherein the enhancer component is present in an amount of 0.4 wt-% to 20 wt-%.

6. The antimicrobial composition of claim 5 , wherein the total concentration of the enhancer component relative to the total amount of the antimicrobial lipid component is within a range of 5:1 and 1:10, on a weight basis.

7. The antimicrobial composition of claim 1 , wherein the surfactant is present in an amount of at least 0.1 wt-% and no greater than 10 wt-%.

8. The antimicrobial composition of claim 7 , wherein the surfactant is present in an amount of 0.1 wt-% to 2 wt-%, and wherein the ratio of the total concentration of the surfactant to the total concentration of antimicrobial lipid component is within a range of 2:1 to 1:3, on a weight basis.

9. The antimicrobial composition of claim 1 , wherein the surfactant comprises a sulfonate, a sulfate, a phosphonate, a phosphate, a poloxamer, a cationic surfactant, or mixtures thereof.

10. The antimicrobial composition of claim 1 , wherein the hydrophilic component includes a polyhydric alcohol, a lower alcohol ether, a short chain ester, and combinations thereof, and wherein the hydrophilic component is soluble in water in an amount of at least 20 wt-% at 23° C.

11. The antimicrobial composition of claim 1 , further comprising a hydrophobic component.

12. The antimicrobial composition of claim 11 , wherein the hydrophobic component is an organic compound that is liquid, gelatinous, semisolid, or solid at 23° C. and has a solubility in water of less than 5 wt-% at 23° C.

13. The antimicrobial composition of claim 1 , wherein the hydrophilic component is selected from glycerol, propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, polyethylene glycol, diethylene glycol, pentaerythritol, trimethylolpropane, trimethylolethane, trimethylolbutane, sorbitol, mannitol, xylitol, pantothenol, ethylene glycol adducts of polyhydric alcohol, propylene oxide adducts of polyhydric alcohol, 1,3-butanediol, dipropylene glycol, diglycerine, polyglycerine, erythritol, sorbitan, sugars, sugar alcohols, or combinations thereof.

14. The antimicrobial composition of claim 1 , wherein the hydrophilic component has a solubility in water of at least 20 wt-% at 23° C.

15. The antimicrobial composition of claim 1 , wherein the viscosity of the composition is at least 500 cps.

16. The antimicrobial composition of claim 1 , wherein the viscosity of the composition is at least 1,000 cps.

17. The antimicrobial composition of claim 1 , wherein the viscosity of the composition is at least 10,000 cps.

18. An antimicrobial composition comprising:

an effective amount of an antimicrobial lipid component having a solubility in water of at least 100 μg/100 g deionized water and at most 1 g/100 g deionized water;

an effective amount of an enhancer component that includes an alpha-hydroxy acid, a beta-hydroxy acid, a chelating agent, a (C1-C4)alkyl carboxylic acid, a (C6-C12)aryl carboxylic acid, a (C6-C12)aralkyl carboxylic acid, a (C6-C12)alkaryl carboxylic acid, a phenolic compound, a (C1-C10)alkyl alcohol, an ether glycol, or combinations thereof;

a surfactant distinct from the antimicrobial lipid component; and

a hydrophilic component other than water, wherein the hydrophilic component other than water forms the greatest portion of the composition by weight;

and wherein the composition contains less than 10 wt-% water when ready to use.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066435/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2013
From: SCHOLZ, MATTHEW T.; GIBBS, DIANNE L.; CAPECCHI, JOHN T.; ANDREWS, JEFFREY F.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 031715/0088 →
Continuity (3)
Continuation 10937059 · Sep 8, 2004
Continuation In Part 10659571 · Sep 9, 2003
Related Publication 20130303615A1 · Nov 14, 2013
Cited By (1)
US 12,448,484